In vivo relative quantitative proteomics reveals HMGB1 as a downstream mediator of oestrogen‐stimulated keratinocyte migration. Issue 6 (27th April 2015)

• Record Type: Journal Article
• Authors: Shin, Jung U; Noh, Ji Yeon; Lee, Ju Hee; Lee, Won Jai; Yoo, Jong Shin; Kim, Jin Young; Kim, Hyeran; Jung, Inhee; Jin, Shan; Lee, Kwang Hoon
• Is Part Of: Experimental dermatology. Volume 24:Issue 6(2015:Jun.)
• Page Start: 478
• Page End: 480
• Publication Date: 2015-04-27
• Subjects: Dermatology -- Periodicals; 616.5
• DOI: 10.1111/exd.12713
• Languages: English
• ISSNs: 0906-6705

Abstract

<abstract abstract-type="main" id="exd12713-abs-0001"> <title>Abstract</title> <p>It is known that oestrogen influences skin wound healing by modulating the inflammatory response, cytokine expression and extracellular matrix deposition; accelerating re‐epithelialization; and stimulating angiogenesis. To identify novel proteins associated with effects of oestrogen on keratinocyte, stable isotope labelling by amino acids in cell culture (SILAC)‐based mass spectrometry was performed. Using SILAC, quantification of 1085 proteins was achieved. Among these proteins, 60 proteins were upregulated and 32 proteins were downregulated. Among significantly upregulated proteins, high‐mobility group protein B1 (HMGB1) has been further evaluated for its role in the effect of oestrogen on keratinocytes. HMGB1 expression was strongly induced in oestrogen‐treated keratinocytes in dose‐ and time‐dependent manner. Further, HMGB1 was able to significantly accelerate the rate of HaCaT cell migration. To determine whether HMGB1 is involved in E2‐induced HaCaT cell migration, cells were transfected with HMGB1 siRNA. Knockdown of HMGB1 blocked oestrogen‐induced keratinocyte migration. Collectively, these experiments demonstrate that HMGB1 is a novel downstream mediator of oestrogen‐stimulated keratinocyte migration.</p> </abstract>